Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth?- Putting resources into Yourself: Self-awareness Techniques
- Figure out How to Score Huge with Open Record Rewards
- An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
- If you want a true taste of Italian paradise, head to Favignana
- Which European countries have mandatory or voluntary military service
- Report in relation to renaming Herzog Park set to be withdrawn
- AfD in Brandenburg takes back suit against the intelligence service
- A Sweet Choice: Pick Your #1 Cake!
